1. Home
  2. FBLG
  3. FBLG News

Latest FIBROBIOLOGICS INC (FBLG) News on February 23, 2025

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
FBLG

GlobeNewswire

18 days ago

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

FibroBiologics And 2 Other US Penny Stocks To Watch
FBLG

Simply Wall St.

18 days ago

FibroBiologics And 2 Other US Penny Stocks To Watch

FBLG

MT Newswires

2 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Equity Purchase Agreement

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
FBLG

GlobeNewswire

2 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing
FBLG

GlobeNewswire

2 months ago

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

FBLG

MT Newswires

2 months ago

FibroBiologics Files Secondary Stock Shelf

FBLG

MT Newswires

2 months ago

FibroBiologics Obtains up to $25 Million Financing

FibroBiologics Announces $25 Million Financing
FBLG

GlobeNewswire

2 months ago

FibroBiologics Announces $25 Million Financing

FBLG

Zacks Small Cap Research

3 months ago

FBLG: On Target to Initiate Phase 1/2 Trial in 2025…

FBLG

MT Newswires

3 months ago

FibroBiologics Files Patent Application for Methods to Treat Splenomegaly

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
FBLG

GlobeNewswire

3 months ago

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
FBLG

GlobeNewswire

3 months ago

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Is FibroBiologics (NASDAQ:FBLG) In A Good Position To Deliver On Growth Plans?
FBLG

Simply Wall St.

3 months ago

Is FibroBiologics (NASDAQ:FBLG) In A Good Position To Deliver On Growth Plans?

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
FBLG

GlobeNewswire

3 months ago

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
FBLG

GlobeNewswire

4 months ago

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
FBLG

GlobeNewswire

4 months ago

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

FibroBiologics and Charles River link for chronic disease therapies manufacture
FBLG

Pharmaceutical Technology

4 months ago

FibroBiologics and Charles River link for chronic disease therapies manufacture

FBLG

MT Newswires

4 months ago

FibroBiologics, Charles River Laboratories Team Up to Make Fibroblast-Based Treatments for Chronic Diseases

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
FBLG

GlobeNewswire

4 months ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

FBLG

MT Newswires

4 months ago

FibroBiologics Gets European Patent for Cancer Treatment Using Modified Fibroblasts

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
FBLG

GlobeNewswire

4 months ago

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit
FBLG

GlobeNewswire

4 months ago

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
FBLG

GlobeNewswire

5 months ago

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

FBLG

MT Newswires

5 months ago

FibroBiologics Enlists Southern Star for Contract Research Organization Services in Australia

FibroBiologics Engages Southern Star Research as CRO in Australia
FBLG

GlobeNewswire

5 months ago

FibroBiologics Engages Southern Star Research as CRO in Australia

FBLG

MT Newswires

5 months ago

FibroBiologics Files Patent Application for Fibroblast Cell-Based Technology

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
FBLG

GlobeNewswire

5 months ago

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
FBLG

GlobeNewswire

6 months ago

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

FBLG

MT Newswires

6 months ago

FibroBiologics Files US Patent Application for Wound Healing

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
FBLG

GlobeNewswire

6 months ago

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

FBLG

Zacks Small Cap Research

6 months ago

FBLG: Proof-of-Concept Data for Artificial Thymus Technology…

FibroBiologics Files 2024 Second Quarter Report
FBLG

GlobeNewswire

6 months ago

FibroBiologics Files 2024 Second Quarter Report

FibroBiologics to Present at JonesTrading Healthcare Summit 2024
FBLG

GlobeNewswire

7 months ago

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
FBLG

GlobeNewswire

8 months ago

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

FBLG

Zacks Small Cap Research

8 months ago

FBLG: Cellular Therapies Using Fibroblasts; Initiating Coverage of FibroBiologics, Inc.

FibroBiologics Set to Join Russell 2000® Index
FBLG

GlobeNewswire

8 months ago

FibroBiologics Set to Join Russell 2000® Index

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
FBLG

GOBankingRates

8 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
FBLG

AFP

8 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
FBLG

AFP

8 months ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally
FBLG

AFP

8 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
FBLG

Business Insider

8 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
FBLG

Insider Monkey

8 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
FBLG

Reuters

8 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

FBLG

Insider Monkey

8 months ago

Best Date Night Fragrance in 2024

Lotto 6/49 - $64 million up for grabs in the next draw!
FBLG

CNW Group

8 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
FBLG

Simply Wall St.

8 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
FBLG

AFP

8 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
FBLG

Simply Wall St.

8 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
FBLG

Simply Wall St.

8 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
FBLG

Barrons.com

8 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
FBLG

Simply Wall St.

8 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
FBLG

Simply Wall St.

8 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
FBLG

GlobeNewswire

9 months ago

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

FibroBiologics Announces 2024 Annual Meeting of Stockholders
FBLG

GlobeNewswire

9 months ago

FibroBiologics Announces 2024 Annual Meeting of Stockholders

FibroBiologics Files 2024 First Quarter Report
FBLG

GlobeNewswire

9 months ago

FibroBiologics Files 2024 First Quarter Report

FibroBiologics to Present at the BIO International Convention 2024
FBLG

GlobeNewswire

10 months ago

FibroBiologics to Present at the BIO International Convention 2024

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
FBLG

GlobeNewswire

10 months ago

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
FBLG

GlobeNewswire

10 months ago

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
FBLG

GlobeNewswire

a year ago

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
FBLG

GlobeNewswire

a year ago

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
FBLG

PR Newswire

a year ago

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

FibroBiologics to Present at Advanced Wound Care Summit USA
FBLG

PR Newswire

a year ago

FibroBiologics to Present at Advanced Wound Care Summit USA

FibroBiologics Appoints Ruben A. Garcia as General Counsel
FBLG

PR Newswire

a year ago

FibroBiologics Appoints Ruben A. Garcia as General Counsel

FibroBiologics Files 2023 Form 10-K Annual Report
FBLG

PR Newswire

a year ago

FibroBiologics Files 2023 Form 10-K Annual Report

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
FBLG

PR Newswire

a year ago

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
FBLG

PR Newswire

a year ago

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

FibroBiologics Announces Three United States Patents for Fibroblast Technology
FBLG

PR Newswire

a year ago

FibroBiologics Announces Three United States Patents for Fibroblast Technology

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology
FBLG

PR Newswire

a year ago

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG
FBLG

PR Newswire

a year ago

FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG

Share on Social Networks: